Analysis saved

DescriptionReuse
No records found.

Methylation Genes Selected

GeneGene regionsRelations to islandOptions
No records found.
ColPortal

Clinical cases

Filtering
Results
Clinical case

CP-1

Nationality: Spa
Status: tumoral
Age: 83
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: left
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: confl
MSI: MSI
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-2

Nationality: Spa
Status: tumoral
Age: 83
Grouped Age: 78+
Type: CRIBIF-COMEDO
Localization: proximal
General loc.: cecum
TNM: T4N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-3

Nationality: Spa
Status: tumoral
Age: 71
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T3N1MX
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: < 50%
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
  • PI3K Exon: 9
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-4

Nationality: Spa
Status: normal
Age: 65
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-5

Nationality: Spa
Status: tumoral
Age: 65
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: sigmoid
TNM: T4N1M1
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: >20 (>12)
Mucina: < 50%
Necrosis: diff
MSI: MSS
Mutations:
  • BRAF
  • PI3K Exon: 9
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-6

Nationality: Spa
Status: tumoral
Age: 72
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-7

Nationality: Spa
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: ascending
TNM: T2N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:

CP-8

Nationality: Spa
Status: normal
Age: 57
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: left
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-9

Nationality: Spa
Status: tumoral
Age: 57
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: left
TNM: T3N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: >20 (>12)
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-10

Nationality: Spa
Status: normal
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-11

Nationality: Spa
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T4N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-12

Nationality: Spa
Status: tumoral
Age: 78
Grouped Age: 78+
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T4N1M0
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: no
TB grading: abs
Mucina: abs
Necrosis: diff
MSI: MSI
Mutations:
  • PI3K Exon: 9
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-13

Nationality: Spa
Status: normal
Age: 56
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-14

Nationality: Spa
Status: tumoral
Age: 56
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T2N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-15

Nationality: Spa
Status: normal
Age: 64
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: rectum
General loc.: sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-16

Nationality: Spa
Status: tumoral
Age: 64
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-17

Nationality: Spa
Status: normal
Age: 83
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.: rectum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-18

Nationality: Spa
Status: tumoral
Age: 83
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.: rectum
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
Methilation:

CP-19

Nationality: Spa
Status: normal
Age: 48
Grouped Age: <= 65
Type: Microsatellite Instable
Localization: proximal
General loc.: ascending
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-20

Nationality: Spa
Status: tumoral
Age: 48
Grouped Age: <= 65
Type: Microsatellite Instable
Localization: proximal
General loc.: ascending
TNM: T3N0M0
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: no
TB grading: abs
Mucina: abs
Necrosis: abs
MSI: MSI
Mutations:
Methilation:

CP-21

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: distal
General loc.: left
TNM: T4N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-22

Nationality: Spa
Status: normal
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-23

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: abs
MSI: MSI
Mutations:
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-24

Nationality: Spa
Status: tumoral
Age: 78
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: ascending
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-25

Nationality: Spa
Status: normal
Age: 64
Grouped Age: <= 65
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-26

Nationality: Spa
Status: tumoral
Age: 64
Grouped Age: <= 65
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T3N2M0
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: no
TB grading: abs
Mucina: < 50%
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-27

Nationality: Spa
Status: tumoral
Age: 66
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T4N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: > 75%
Necrosis: intrag
MSI: MSS
Mutations:
  • PI3K Exon: 20
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-28

Nationality: Spa
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: proximal
General loc.: ascending
TNM: T4N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-29

Nationality: Spa
Status: tumoral
Age: 54
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: proximal
General loc.: transverse
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
  • PI3K Exon: 20
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-30

Nationality: Spa
Status: tumoral
Age: 39
Grouped Age: <= 65
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T3N0M0
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: no
TB grading: abs
Mucina: abs
Necrosis: diff
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-31

Nationality: Spa
Status: normal
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-32

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T4N2M1
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: < 50%
Necrosis: intrag
MSI: MSS
Mutations:
  • BRAF
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(parcial met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-33

Nationality: Spa
Status: tumoral
Age: 65
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T4N2M0
Grading: LG
Invasion:
Perforation:
Growth:
Budding:
TB grading:
Mucina: abs
Necrosis:
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-34

Nationality: Spa
Status: normal
Age: 68
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-35

Nationality: Spa
Status: tumoral
Age: 68
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T4N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: < 50%
Necrosis: abs
MSI: MSS
Mutations:
  • BRAF
  • KRAS
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-36

Nationality: Spa
Status: tumoral
Age: 74
Grouped Age: 74 - 77
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T4N1M1
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-37

Nationality: Spa
Status: tumoral
Age: 85
Grouped Age: 78+
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: < 50%
Necrosis: diff
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-38

Nationality: Spa
Status: tumoral
Age: 67
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T3N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-39

Nationality: Spa
Status: tumoral
Age: 73
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.: ascending
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-40

Nationality: Spa
Status: tumoral
Age: 71
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: ascending
TNM: T2N0M1
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: 10-19 (>12)
Mucina: 50-75%
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-41

Nationality: Spa
Status: tumoral
Age: 86
Grouped Age: 78+
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T3N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSI
Mutations:
  • KRAS
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-42

Nationality: Spa
Status: normal
Age: 77
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-43

Nationality: Spa
Status: tumoral
Age: 77
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T4N2MX
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: > 75%
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-44

Nationality: Spa
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-45

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-46

Nationality: Spa
Status: tumoral
Age: 64
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: splenic
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding:
TB grading: 10-19 (>12)
Mucina: < 50%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
  • PI3K Exon: 9
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-47

Nationality: Spa
Status: tumoral
Age: 74
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T3N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-48

Nationality: Spa
Status: tumoral
Age: 63
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-49

Nationality: Spa
Status: normal
Age: 69
Grouped Age: 66 - 73
Type: Microsatellite Instable
Localization: proximal
General loc.: ascending
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-50

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Microsatellite Instable
Localization: proximal
General loc.: ascending
TNM: T4N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: 50-75%
Necrosis: diff
MSI: MSI
Mutations:
  • KRAS
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-51

Nationality: Spa
Status: tumoral
Age: 65
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: transverse
TNM: T3N0M0
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-52

Nationality: Spa
Status: tumoral
Age: 80
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T4N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-53

Nationality: Spa
Status: tumoral
Age: 91
Grouped Age: 78+
Type: Conventional Carcinoma
Localization: proximal
General loc.: transverse
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-54

Nationality: Spa
Status: normal
Age: 76
Grouped Age: 74 - 77
Type: Microsatellite Instable
Localization: proximal
General loc.: ascending
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-55

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Microsatellite Instable
Localization: proximal
General loc.: ascending
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: no
TB grading: abs
Mucina: < 50%
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-56

Nationality: Spa
Status: normal
Age: 69
Grouped Age: 66 - 73
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-57

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T4N0M1
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: >20 (>12)
Mucina: abs
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-58

Nationality: Spa
Status: normal
Age: 72
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-59

Nationality: Spa
Status: tumoral
Age: 72
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-60

Nationality: Spa
Status: normal
Age: 65
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-61

Nationality: Spa
Status: tumoral
Age: 65
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: T3N0M0
Grading:
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
  • PI3K Exon: 20
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-62

Nationality: Spa
Status: tumoral
Age: 79
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: < 50%
Necrosis: intrag
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-63

Nationality: Spa
Status: tumoral
Age: 78
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: left
TNM: T2N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: 10-19 (>12)
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-64

Nationality: Spa
Status: normal
Age: 66
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: abs
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-65

Nationality: Spa
Status: tumoral
Age: 66
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: <10 (0-5)
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-66

Nationality: Spa
Status: normal
Age: 78
Grouped Age: 78+
Type: Conventional Carcinoma
Localization: proximal
General loc.: ascending
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-67

Nationality: Spa
Status: tumoral
Age: 78
Grouped Age: 78+
Type: Conventional Carcinoma
Localization: proximal
General loc.: ascending
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-68

Nationality: Spa
Status: tumoral
Age: 70
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
  • KRAS
  • PI3K Exon: 9
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-69

Nationality: Spa
Status: normal
Age: 76
Grouped Age: 74 - 77
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-70

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Microsatellite Instable
Localization: proximal
General loc.: cecum
TNM: T3N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: >20 (>12)
Mucina: 50-75%
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-71

Nationality: Spa
Status: normal
Age: 88
Grouped Age: 78+
Type: Conventional Carcinoma
Localization: rectum
General loc.: rectum-sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-72

Nationality: Spa
Status: tumoral
Age: 88
Grouped Age: 78+
Type: Conventional Carcinoma
Localization: rectum
General loc.: rectum-sigmoid
TNM: T3N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-73

Nationality: Spa
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: distal
General loc.: sigmoid
TNM: T4N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-74

Nationality: Spa
Status: tumoral
Age: 54
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N2M1
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • BRAF
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-75

Nationality: Spa
Status: normal
Age: 77
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-76

Nationality: Spa
Status: tumoral
Age: 77
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: sigmoid
TNM: T4N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: 50-75%
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-77

Nationality: Spa
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: TisN0M0
Grading: LG
Invasion: false
Perforation: false
Growth: NP
Budding: NO
TB grading: abs
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-78

Nationality: Spa
Status: normal
Age: 74
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-79

Nationality: Spa
Status: tumoral
Age: 74
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-80

Nationality: Spa
Status: normal
Age: 73
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-81

Nationality: Spa
Status: tumoral
Age: 73
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.: cecum
TNM: T3N0M0
Grading:
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: < 50%
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-82

Nationality: Spa
Status: tumoral
Age: 80
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.: rectum
TNM: T3N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(parcial met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-83

Nationality: Spa
Status: normal
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization:
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: abs
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-84

Nationality: Spa
Status: normal
Age: 88
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-85

Nationality: Spa
Status: tumoral
Age: 88
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-86

Nationality: Spa
Status: normal
Age: 77
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: ascending
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-87

Nationality: Spa
Status: tumoral
Age: 77
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: ascending
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: 10-19 (>12)
Mucina: 50-75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-88

Nationality: Spa
Status: tumoral
Age: 63
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: 50-75%
Necrosis: abs
MSI: MSI
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-89

Nationality: Spa
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-90

Nationality: Spa
Status: tumoral
Age: 81
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: < 50%
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-91

Nationality: Spa
Status: tumoral
Age: 78
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-92

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Microsatellite Instable
Localization: proximal
General loc.:
TNM: T4N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: 50-75%
Necrosis: diff
MSI: MSI
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-93

Nationality: Spa
Status: tumoral
Age: 83
Grouped Age: 78+
Type: Microsatellite Instable
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: < 50%
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(parcial met)

CP-94

Nationality: Spa
Status: tumoral
Age: 80
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: intrag
MSI:
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-95

Nationality: Spa
Status: tumoral
Age: 70
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: TisN0M0
Grading: LG
Invasion: false
Perforation: false
Growth: NP
Budding: no
TB grading: abs
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-96

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T3N2M1
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(parcial met)

CP-97

Nationality: Spa
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-98

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T4N2M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-99

Nationality: Spa
Status: tumoral
Age: 62
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: rectum
General loc.:
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-100

Nationality: Spa
Status: tumoral
Age: 87
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T4N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-101

Nationality: Spa
Status: tumoral
Age: 77
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-102

Nationality: Spa
Status: tumoral
Age: 65
Grouped Age: <= 65
Type: Microsatellite Instable
Localization: distal
General loc.:
TNM: T4N1M0
Grading: HG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-103

Nationality: Spa
Status: tumoral
Age: 88
Grouped Age: 78+
Type: Microsatellite Instable
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-104

Nationality: Spa
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: intrag
MSI:
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(parcial met)

CP-105

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: proximal
General loc.:
TNM: T3N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-106

Nationality: Spa
Status: tumoral
Age: 51
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(met)
  • SOCS1(no met)

CP-107

Nationality: Spa
Status: tumoral
Age: 81
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-108

Nationality: Spa
Status: tumoral
Age: 64
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-109

Nationality: Spa
Status: normal
Age: 68
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N1M1
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: NOS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-110

Nationality: Spa
Status: tumoral
Age: 68
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T2N2M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-111

Nationality: Spa
Status: tumoral
Age: 68
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-112

Nationality: Spa
Status: tumoral
Age: 67
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: T4N2M1
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: > 75%
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-113

Nationality: Spa
Status: tumoral
Age: 46
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: rectum
General loc.:
TNM: T3N1MX
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-114

Nationality: Spa
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: abs
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-115

Nationality: Spa
Status: tumoral
Age: 84
Grouped Age: 78+
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: T4N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(parcial met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-116

Nationality: Spa
Status: tumoral
Age: 85
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-117

Nationality: Spa
Status: tumoral
Age: 79
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: High
TB grading: 10-19 (>12)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-118

Nationality: Spa
Status: tumoral
Age: 64
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T3N1M1
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: abs
MSI: MSS
Mutations:
  • BRAF
  • KRAS
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-119

Nationality: Spa
Status: tumoral
Age: 56
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: proximal
General loc.:
TNM: TisN0M0
Grading: LG
Invasion: false
Perforation: false
Growth: NP
Budding: NO
TB grading: abs
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(no met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-120

Nationality: Spa
Status: tumoral
Age: 67
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.:
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-121

Nationality: Spa
Status: tumoral
Age: 87
Grouped Age: 78+
Type: Conventional Carcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: < 50%
Necrosis: confl
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-122

Nationality: Spa
Status: tumoral
Age: 51
Grouped Age: <= 65
Type: Microsatellite Instable
Localization: rectum
General loc.:
TNM: T3N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: abs
Mucina: abs
Necrosis: intrag
MSI: MSI
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-123

Nationality: Spa
Status: tumoral
Age: 78
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: > 75%
Necrosis: intrag
MSI:
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-124

Nationality: Fin
Status: normal
Age: 88
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-125

Nationality: Fin
Status: normal
Age: 46
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-126

Nationality: Fin
Status: normal
Age: 60
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization:
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-127

Nationality: Fin
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N2M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: no
Necrosis: confl
MSI:
Mutations:
  • BRAF
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(parcial met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-128

Nationality: Fin
Status: tumoral
Age: 88
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: <50% (<10%)
Necrosis: intrag
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-129

Nationality: Fin
Status: tumoral
Age: 86
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: 50-75%
Necrosis: abs
MSI: MSS
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(parcial met)

CP-130

Nationality: Fin
Status: tumoral
Age: 72
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T4N2M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (6-11)
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-131

Nationality: Fin
Status: tumoral
Age: 84
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T2N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: <50%
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-132

Nationality: Fin
Status: tumoral
Age: 68
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T4N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: <50%
Necrosis: abs
MSI: MSS
Mutations:
  • BRAF
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-133

Nationality: Fin
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: proximal
General loc.:
TNM: T3N2M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: <50%
Necrosis: confl
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(met)
  • CDKN2A(no met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(parcial met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-134

Nationality: Fin
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N2M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: >75%
Necrosis: abs
MSI: MSS
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(no met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(parcial met)

CP-135

Nationality: Fin
Status: tumoral
Age: 70
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T4N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: 50-75%
Necrosis: abs
MSI: MSI
Mutations:
  • BRAF
Methilation:
  • CACNA1G(met)
  • CDKN2A(parcial met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(met)
  • NEUROG1(met)
  • RUNX3(parcial met)
  • SOCS1(no met)

CP-136

Nationality: Fin
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: proximal
General loc.:
TNM: T3N1M1
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (6-11)
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-137

Nationality: Fin
Status: tumoral
Age: 68
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: rectum
General loc.:
TNM: T3N2M1
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • BRAF
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(met)
  • SOCS1(no met)

CP-138

Nationality: Fin
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N2M1
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (6-11)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-139

Nationality: Fin
Status: tumoral
Age: 72
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-140

Nationality: Fin
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (6-11)
Mucina: >75%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(parcial met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-141

Nationality: Fin
Status: tumoral
Age: 63
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: rectum
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-142

Nationality: Fin
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: <50% (<10%)
Necrosis: intrag
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-143

Nationality: Fin
Status: tumoral
Age: 73
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: rectum
General loc.:
TNM: T3N1M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-144

Nationality: Fin
Status: tumoral
Age: 78
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: 10-19 (6-11)
Mucina: <50%
Necrosis: diffuse
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(parcial met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-145

Nationality: Fin
Status: tumoral
Age: 46
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: <50%
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-146

Nationality: Fin
Status: tumoral
Age: 60
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: <50%
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-147

Nationality: Fin
Status: tumoral
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: 10-19 (>12)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-148

Nationality: Fin
Status: tumoral
Age: 74
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T3N2M0
Grading: HG
Invasion: false
Perforation: false
Growth: inf
Budding: High
TB grading: >20 (>12)
Mucina: <50%
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-149

Nationality: Fin
Status: tumoral
Age: 74
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T3N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(no met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-150

Nationality: Fin
Status: normal
Age: 73
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization:
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-151

Nationality: Fin
Status: normal
Age: 60
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization:
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-152

Nationality: Fin
Status: normal
Age: 75
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-153

Nationality: Fin
Status: tumoral
Age: 52
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: inf
Budding: Low
TB grading: <10 (6-11)
Mucina: abs
Necrosis: intrag
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-154

Nationality: Fin
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: abs
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(parcial met)
  • CRABP1(parcial met)
  • IGF2(parcial met)
  • MLH1(no met)
  • NEUROG1(parcial met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-155

Nationality: Fin
Status: tumoral
Age: 71
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: rectum
General loc.:
TNM: T4N1M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (0-5)
Mucina: abs
Necrosis: diff
MSI: MSS
Mutations:
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(parcial met)
  • MLH1(parcial met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-156

Nationality: Fin
Status: tumoral
Age: 71
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: rectum
General loc.:
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: exp
Budding: Low
TB grading: <10 (6-11)
Mucina: abs
Necrosis: confl
MSI: MSS
Mutations:
  • KRAS
Methilation:
  • CACNA1G(no met)
  • CDKN2A(no met)
  • CRABP1(no met)
  • IGF2(no met)
  • MLH1(no met)
  • NEUROG1(no met)
  • RUNX3(no met)
  • SOCS1(no met)

CP-157

Nationality: Fin
Status: normal
Age: 75
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-158

Nationality: Fin
Status: normal
Age: 78
Grouped Age: 78+
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-159

Nationality: Spa
Status: tumoral
Age: 42
Grouped Age: <= 65
Type: Mucinous Adenoma
Localization: distal
General loc.: sigmoid
TNM: T3N1MX
Grading:
Invasion:
Perforation:
Growth:
Budding:
TB grading:
Mucina:
Necrosis:
MSI: MSS
Mutations:
Methilation:

CP-160

Nationality: Spa
Status: tumoral
Age: 64
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.: rectum
TNM: T3N0M0
Grading: LG
Invasion: false
Perforation: false
Growth:
Budding: High
TB grading: >20
Mucina: > 75%
Necrosis: abs
MSI: MSS
Mutations:
Methilation:

CP-161

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Conventional Carcinoma
Localization: rectum
General loc.: rectum
TNM: T3N1MX
Grading:
Invasion:
Perforation:
Growth:
Budding:
TB grading:
Mucina:
Necrosis:
MSI: MSS
Mutations:
Methilation:

CP-162

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Serrated Adenocarcinoma
Localization: distal
General loc.: sigmoid
TNM: T1N0M0
Grading: LG
Invasion: false
Perforation: false
Growth: expansivo
Budding: Low
TB grading: 0
Mucina: > 75%
Necrosis: abs
MSI:
Mutations:
Methilation:

CP-163

Nationality: Spa
Status: tumoral
Age: 63
Grouped Age: <= 65
Type: Serrated Adenocarcinoma
Localization: rectum
General loc.: sigmoid
TNM: T3N2MX
Grading: LG
Invasion: false
Perforation: false
Growth:
Budding: Low
TB grading: <10
Mucina:
Necrosis: abs
MSI: MSS
Mutations:
Methilation:

CP-164

Nationality: Spa
Status: tumoral
Age: 69
Grouped Age: 66 - 73
Type: Serrated Adenocarcinoma
Localization: proximal
General loc.: cecum
TNM: T4N2MX
Grading:
Invasion: false
Perforation:
Growth:
Budding: Low
TB grading: <10
Mucina: < 50%
Necrosis:
MSI: MSI-H
Mutations:
Methilation:

CP-166

Nationality: Spa
Status: tumoral
Age: 59
Grouped Age: <= 65
Type: Mucinous Adenoma
Localization: rectum
General loc.: rectum
TNM: T3N0M0
Grading:
Invasion:
Perforation:
Growth:
Budding:
TB grading:
Mucina:
Necrosis:
MSI:
Mutations:
Methilation:

CP-167

Nationality: Spa
Status: tumoral
Age: 61
Grouped Age: <= 65
Type: Conventional Carcinoma
Localization: rectum
General loc.: rectum
TNM: T3N2MX
Grading:
Invasion: false
Perforation: false
Growth:
Budding:
TB grading:
Mucina:
Necrosis: confl
MSI:
Mutations:
Methilation:

CP-168

Nationality: Spa
Status: tumoral
Age: 76
Grouped Age: 74 - 77
Type: Conventional Carcinoma
Localization: distal
General loc.:
TNM: T3N1MX
Grading:
Invasion:
Perforation:
Growth:
Budding:
TB grading:
Mucina:
Necrosis:
MSI: MSS
Mutations:
Methilation:

CP-169

Nationality: Spa
Status: polyp
Age: 71
Grouped Age: 66 - 73
Type: NOS
Localization: proximal
General loc.: ascending
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-170

Nationality: Spa
Status: normal
Age: 64
Grouped Age: <= 65
Type: NOS
Localization:
General loc.: rectum
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-171

Nationality: Spa
Status: polyp
Age: 76
Grouped Age: 74 - 77
Type: NOS
Localization: distal
General loc.: sigmoid
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-172

Nationality: Spa
Status: normal
Age: 65
Grouped Age: <= 65
Type: NOS
Localization: proximal
General loc.: cecum
TNM: NOSNOSNOS
Grading: NOS
Invasion: false
Perforation: false
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-194

Nationality: Spa
Status: polyp
Age: 66
Grouped Age: 66 - 73
Type: Tubular Adenoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-195

Nationality: Spa
Status: polyp
Age: 62
Grouped Age: <= 65
Type: Tubular Adenoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-196

Nationality: Spa
Status: polyp
Age: 78
Grouped Age: 78+
Type: Traditional serrated adenoma+Tubular villious adenoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-197

Nationality: Spa
Status: polyp
Age: 78
Grouped Age: 78+
Type: Tubular villious adenoma+Pathological tumor in situ
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-198

Nationality: Spa
Status: polyp
Age: 72
Grouped Age: 66 - 73
Type: Traditional serrated adenoma+Tubular villious adenoma+High grade dysplasia
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-199

Nationality: Spa
Status: normal
Age: 71
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-200

Nationality: Spa
Status: normal
Age: 78
Grouped Age: 78+
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-201

Nationality: Spa
Status: polyp
Age: 78
Grouped Age: 78+
Type: Tubular villious adenoma+Pathological tumor in situ
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-202

Nationality: Spa
Status: normal
Age: 71
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-203

Nationality: Spa
Status: normal
Age: 42
Grouped Age: <= 65
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-204

Nationality: Spa
Status: normal
Age: 71
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-205

Nationality: Spa
Status: normal
Age: 42
Grouped Age: <= 65
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-206

Nationality: Spa
Status: normal
Age: 63
Grouped Age: <= 65
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-207

Nationality: Spa
Status: normal
Age: 63
Grouped Age: <= 65
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-208

Nationality: Spa
Status: normal
Age: 45
Grouped Age: <= 65
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-209

Nationality: Spa
Status: polyp
Age: 68
Grouped Age: 66 - 73
Type: Tubular adenoma+Low grade dysplasia
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-210

Nationality: Spa
Status: normal
Age: 45
Grouped Age: <= 65
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-211

Nationality: Spa
Status: polyp
Age: 87
Grouped Age: 78+
Type: Villious Adenoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-212

Nationality: Spa
Status: polyp
Age: 70
Grouped Age: 66 - 73
Type: Tubular Villious Adenoma
Localization:
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-213

Nationality: Spa
Status: polyp
Age: 85
Grouped Age: 78+
Type: Tubular Villious Adenoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-214

Nationality: Spa
Status: polyp
Age: 81
Grouped Age: 78+
Type: Traditional serrated adenoma+Tubular villious adenoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-215

Nationality: Spa
Status: polyp
Age: 88
Grouped Age: 78+
Type: Sesil Serrated Adenoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-216

Nationality: Spa
Status: polyp
Age: 78
Grouped Age: 78+
Type: Tubular Adenoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-217

Nationality: Spa
Status: polyp
Age: 90
Grouped Age: 78+
Type: Traditional serrated adenoma+Pathological tumor in situ
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-218

Nationality: Spa
Status: polyp
Age: 62
Grouped Age: <= 65
Type: Traditional serrated adenoma+Pathological tumor in situ
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-219

Nationality: Spa
Status: polyp
Age: 70
Grouped Age: 66 - 73
Type: Tubular Adenoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-220

Nationality: Spa
Status: polyp
Age: 51
Grouped Age: <= 65
Type: Tubular Adenoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-221

Nationality: Spa
Status: polyp
Age: 68
Grouped Age: 66 - 73
Type: Tubular Adenoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-222

Nationality: Spa
Status: polyp
Age: 75
Grouped Age: 74 - 77
Type: Traditional serrated adenoma+Tubular villious adenoma+Pathological tumor in situ
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-223

Nationality: Spa
Status: normal
Age: 70
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-224

Nationality: Spa
Status: normal
Age: 70
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-225

Nationality: Spa
Status: normal
Age: 66
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-226

Nationality: Spa
Status: normal
Age: 66
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-227

Nationality: Spa
Status: normal
Age: 78
Grouped Age: 78+
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-228

Nationality: Spa
Status: normal
Age: 78
Grouped Age: 78+
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-229

Nationality: Spa
Status: normal
Age: 62
Grouped Age: <= 65
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-230

Nationality: Spa
Status: polyp
Age: 70
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-231

Nationality: Spa
Status: polyp
Age: 84
Grouped Age: 78+
Type: Tubular villious adenoma+Pathological tumor in situ
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-232

Nationality: Spa
Status: polyp
Age: 72
Grouped Age: 66 - 73
Type: Traditional serrated adenoma+Pathological tumor in situ
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-233

Nationality: Spa
Status: polyp
Age: 62
Grouped Age: <= 65
Type: Villious Adenoma+High grade dysplasia
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-234

Nationality: Spa
Status: polyp
Age: 73
Grouped Age: 66 - 73
Type: Tubular Adenoma
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-235

Nationality: Spa
Status: normal
Age: 73
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-236

Nationality: Spa
Status: normal
Age: 73
Grouped Age: 66 - 73
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-237

Nationality: Spa
Status: normal
Age: 81
Grouped Age: 78+
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-238

Nationality: Spa
Status: polyp
Age: 70
Grouped Age: 66 - 73
Type: Tubular Adenoma
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-239

Nationality: Spa
Status: normal
Age: 81
Grouped Age: 78+
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-240

Nationality: Spa
Status: polyp
Age: 81
Grouped Age: 78+
Type: Serrated adenoma+Tubular Villious Adenoma+Pathological Tumor In Situ
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-241

Nationality: Spa
Status: normal
Age: 83
Grouped Age: 78+
Type: Normal Mucose
Localization:
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-242

Nationality: Spa
Status: polyp
Age: 83
Grouped Age: 78+
Type: Traditional serrated adenoma+Pathological tumor in situ
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-243

Nationality: Spa
Status: normal
Age: 62
Grouped Age: <= 65
Type: Normal Mucose
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-244

Nationality: Spa
Status: normal
Age: 62
Grouped Age: <= 65
Type: Normal Mucose
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-245

Nationality: Spa
Status: polyp
Age: 79
Grouped Age: 78+
Type: Tubular villious adenoma+High grade dysplasia
Localization: proximal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-246

Nationality: Spa
Status: polyp
Age: 54
Grouped Age: <= 65
Type: Sesil serrated adenoma+Pathological Tumor In Situ
Localization: distal
General loc.:
TNM: NOSNOSNOS
Grading: NOS
Invasion:
Perforation:
Growth: NOS
Budding: NOS
TB grading: NOS
Mucina: NOS
Necrosis: NOS
MSI: NOS
Mutations:
Methilation:

CP-247

Nationality: Spa
Status: polyp
Age: 71
Grouped Age: 66 - 73
Type: Tubular Villious Adenoma
Localization: proximal
General loc.:
TNM: NOSNOSN